Klotho Neurosciences Announces Expiration of Letter of Intent
Provided By PR Newswire
Last update: Oct 8, 2025
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire by the parties.
Read more at prnewswire.com
